Debiopharm Innovation Fund Investors
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Invests into
Estimated Revenue:
$4.7M.
Founded Date:
2012-01-01
Zip:
NA
Investor Type:
Venture Capital
Headquarters:
Lausanne, Vaud, Switzerland
Acquisitions Number:
NA
Funding Status:
N/A
Employee Number:
1-10
Number Of Exists:
6
Industry:
Imaging
Investment Stage:
Late Stage Venture, Venture
Investors Number:
24